To investigate whether MDSCs infiltration were involved in HOXB5-mediated HCC metastasis, CXCR2 inhibitor SB265610 was used to decrease the chemotaxis of MDSCs in vivo. The gene discussed is HOXB5; the disease is hepatocellular carcinoma.